Market revenue in 2023 | USD 10.1 million |
Market revenue in 2030 | USD 16.6 million |
Growth rate | 7.4% (CAGR from 2023 to 2030) |
Largest segment | Copolymer pom |
Fastest growing segment | Copolymer POM |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Homopolymer POM, Copolymer POM |
Key market players worldwide | Dow Inc, Celanese Corp Class A, DuPont de Nemours Inc, Daicel Corp, Asahi Kasei Corp, Mitsubishi Gas Chemical Co Inc, SABIC, Avient Corp, Clariant AG, Jet-Hot, Innovative Plastics, Korea Engineering Plastics Co., China National Bluestar Group, ICD High Performance Coatings |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to medical polyoxymethylene (pom) market will help companies and investors design strategic landscapes.
Copolymer pom was the largest segment with a revenue share of 63.37% in 2023. Horizon Databook has segmented the China medical polyoxymethylene (pom) market based on homopolymer pom, copolymer pom covering the revenue growth of each sub-segment from 2018 to 2030.
China is the world’s second-largest healthcare market, after the U.S. According to the U.S. International Trade Administration, the public sector hospitals in China (totaling around 36,570 as of 2021) are the largest buyers of medical equipment and devices.
In 2021, the diagnostic imaging and consumables constituted about half of the total medical devices market value in China in 2021, forming major consumers of medical POM in the country. In April 2021, the government of China announced the enactment of a medical technology five-year plan starting from 2021 to 2025, for making at least 6 Chinese firms reach the top 50 medical devices companies list globally.
This plan includes initiatives such as the buying of bulk quantities of medical devices by the central government for public sector hospitals, incentives for manufacturing units, and a reduction in export tariffs.
Horizon Databook provides a detailed overview of country-level data and insights on the China medical polyoxymethylene (pom) market , including forecasts for subscribers. This country databook contains high-level insights into China medical polyoxymethylene (pom) market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account